HER2 Chimeric Antigen Receptor (CAR) T Cells in Combination With Checkpoint Blockade in Patients With Advanced Sarcoma

NCT04995003 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Sarcoma
HER-2 Protein Overexpression
Osteosarcoma
Rhabdomyosarcoma
Ewing Sarcoma
Synovial Sarcoma
Soft Tissue Sarcoma
Undifferentiated Sarcoma

Interventions

GENETIC: T cells or CAR T cells
DRUG: Pembrolizumab Injectable Product
DRUG: Nivolumab Injectable Product

Sponsor

Baylor College of Medicine

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]